Biotronik Se Co. Kg

Biotronik Crm Patent Ag

Rolls-royce Deutschland Ltd & Co. Kg

Dyconex Ag

Biotronik Ag

Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingeniuerbuero Berlin

Thomas Doerr

Ingo Weiss

Torsten Radtke

Sergey Ershov

Michael Diebold

Martin Roemer

Torsten Oertmann

Dirk Muessig

Carsten Clemen

Ulrich Busch

Frank Becker

Rolf Klenner

Ulrich Feese

Peter Schneider

Ulrich Tietze

Gernot Kolberg

Marc Hauer

Stefan Paule

Leif Rackwitz

Erhard Flach

Volker Lang

Tim Traulsen

Andreas Neumann

Joachim Reinke

Andreas Kucher

Waldemar Lazik

Sebastian Bake

Frank Tscherch

Torsten Lang

Miklos Gerendas

Alexander Borck

R Hollis Whittington

Imon-Kalyan Bagchi

Alan Fryer

Stefan Penz

Joachim Elsner

Shayan Guhaniyogi

Ravi Kiran Kondama Reddy

Miklós Gerendás

Carsten Hennig

Georg Nollert

Christian Rehdorf

Guenter Breithardt

Thomas Fetsch

Joerg Fregien

Tino Hauser

Gregory Jay Delmain

André Burch

Peter Blachut

Rainer-Michael Schmidt

Torsten Dodt

Kai Hensen

Steffen Kibbel

Uwe Stuermer

Torsten Voigt

Hans-Joerg Bauer

Rainer Koch

Thilo Dauch

Bjoern Henrik Diem

Dominic Wist

Daniel Krueger

An implantable medical device for stimulating a heart, includes a stimulation electrode configured to stimulate a first cardiac region of the heart, and a detection unit configured to detect an intracardiac electrogram at a second cardiac region (ventricle) of the heart. In operation, the device: delivers a stimulation pulse to the heart; evaluates a time and at least one morphologic parameter of a responsive signal of an intracardiac electrogram, wherein the at least one morphologic parameter is chosen from: an absolute value of the signal amplitude, a width of the signal, a positive, negative and/or total area under at least a part of the signal, and a number of occurrences and/or time of occurrence of zero crossings of the signal; and identifies a dislocation of the stimulation electrode if the time of the signal is below a first threshold value and the morphologic parameter exceeds a further threshold value.

Implantable medical device with electrode dislocation recognition

An implantable medical device comprises a housing, a circuit board structure arranged within in the housing and comprising at least one flexible section, an electronic module comprising at least one electronic component arranged on the circuit board structure, and an energy storage device for providing electrical energy for operation of the implantable medical device. The energy storage device is a solid-state battery mounted on the circuit board structure. An energy generation device connected to the energy storage device is a secondary cell, wherein the energy generation device is configured to convert patient energy to electrical energy for charging the energy storage device.

Implantable medical device comprising an energy storage device

A programming device for programming an implantable medical device for stimulating a human or animal heart, wherein the following steps are performed: a) allowing to select one of at least two electrode lead configurations for stimulating a human or animal heart, wherein the at least two electrode lead configurations comprise a second electrode lead configuration in which at least one electrode lead is connected to an electrode lead port, the electrode lead port being configured to receive an electrode lead for stimulating a second cardiac region or detecting an electric signal at the second cardiac region, wherein the second cardiac region is a part of a ventricular conduction system of the heart, wherein the at least one electrode lead is intended to be implanted or is implanted in the second cardiac region; b) generating and releasing a notification signal if the second electrode lead configuration is selected.

Programming device for programming an implantable medical device for stimulating a human or animal heart

An implantable device for stimulating a heart to lower blood pressure, comprising: a stimulation unit configured to stimulate a ventricle, and a sensing unit for detecting atrial activity of the heart, wherein the stimulation unit is configured to stimulate the ventricle for at least one cardiac cycle with a predefined delay after detection of an atrial activity or to not stimulate the ventricle for at least one cardiac cycle.

Hypertension therapy

An implantable leadless pacemaker configured to provide antibradycardia pacing of a human or animal heart, comprising: an electrical energy source, a sensor configured to sense intracardiac potentials of the heart, a pulse generator configured to generate electrical pacing pulses, a control unit for controlling the pulse generator, wherein the control unit is configured to inhibit generation of an electrical pacing pulse when an intracardiac potential is sensed, wherein the control unit is further configured to permanently switch off the pulse generator after passing of a predetermined timespan and/or after a pre-defined event detected by the pacemaker, an electrode pole for electrical stimulation and sensing intracardiac potentials, at least one fastening element for fastening the pacemaker to heart tissue, wherein the implantable leadless pacemaker is adapted such that a lifetime of the implantable leadless pacemaker is smaller than one year, particularly smaller than one month, particularly smaller than two weeks.

Temporary implantable leadless pacemaker

The disclosure relates to an implant comprising an electronics module and an electronic component, wherein an electrical connection between the electronics module and the electronic component is formed by a straight plug-in connection. A method for producing an electrical connection between an electronics module and an electronic component of an implant is also disclosed.

Implant and method for producing an electrical connection between an electronics module and an electronic component of an implant

The present invention relates an implantable pulse generator comprising an electric circuit, wherein the electric circuit comprises: a primary energy store, at least one secondary energy store, and a control unit, wherein the control unit is configured to activate an electric switch in the electric circuit in such a way that, in a first interval of a first phase of a pulse delivery, the primary energy store is discharged via a therapeutic current path, and to activate an electric switch in the electric circuit in such a way that, in a second interval of the first phase of the pulse delivery, the secondary energy store is discharged via the therapeutic current path, wherein the primary energy store and the at least one secondary energy store are fixedly connected, or connectable, in series, and wherein the implantable pulse generator is designed to deliver a shock having an approximately rectangular pulse waveform.

Implantable pulse generator having rectangular shock waveform

An implantable medical device comprises a functional device for carrying out a therapeutic or diagnostic function, and a communication device for communicating with a remote monitoring system. The communication device, at a start of initial operation of the implantable medical device, is enabled to establish a communication with said remote monitoring system. In this way an implantable medical device is provided which allows for including the implantable medical device in a remote monitoring while reducing a risk for a patient involved with attending to the patient for activating a remote monitoring function within the implantable medical device.

System for generating an alert for a systemic infection

An implantable medical device which performs the following steps during operation: a) performing a detection of whether the implantable medical device is in an implanted state; b) if it is detected that the implantable medical device is in an implanted state, activating a first diagnostic or therapeutic function of the implantable medical device, and subsequently activating a second diagnostic or therapeutic function of the implantable medical device, wherein the second diagnostic or therapeutic function is activated only after the fulfillment of at least one activation criterion selected from the group consisting of an elapse of a first time period from the activation of the first diagnostic or therapeutic function, an elapse of a second time period from the detection that the implantable medical device is in an implanted state, and a passing of a function test.

Implantable medical device

An implantable medical device for stimulating a human or animal heart. In operation, the device performs the following steps: a) sensing an atrial electric signal a the first detection unit; b) sensing an electric signal at the His bundle with a second detection unit upon termination of a first time period starting upon sensing the atrial electric signal with the first detection unit and/or starting upon applying a stimulation pulse, wherein the first time period lies in a range of from 10 ms to 100 ms; c) classifying the electric signal sensed with the second detection unit as His bundle activity signal or as ventricular activity signal.

Implantable medical device for stimulating the His bundle of a human or animal heart employing an improved distinction between atrial and ventricular signals detected at the His bundle

The disclosure relates to an implant comprising a housing, in which there are arranged an energy store and an electronics module, wherein a feedthrough to an electrode connection device is formed on the housing, wherein a first contact forms an electrical connection between the energy store and the electronics module, wherein a second contact forms an electrical connection between the electronics module and the feedthrough, and wherein the first contact and the second contact are oriented in the same contact direction. A method for assembling an implant is also disclosed.

Implant and method for assembling an implant

An active medical device, comprising a processor, a memory unit, and at least one of an accelerometer and a detection unit configured to detect a body impedance. During operation, the active medical device carries out the following steps: a) measuring a body impedance of a patient with the detection unit during a first period of time to obtain time-dependent impedance data and calculating a power spectral density of the impedance data; b) alternatively or additionally to step a), measuring an acceleration of a body of the patient with the accelerometer during the first period of time to obtain time-dependent acceleration data and calculating a power spectral density of the acceleration data; c) identifying coughing of the patient on the basis of the calculated power spectral density if at least 1% of all values of the power spectral density have a frequency of at least 1 Hz.

Active medical device capable of identifying coughing

A device housing for an IMD is suggested, the device housing having: wherein the ratio R of maximum width (Bmax) to maximum height (Hmax), i.e., Bmax/Hmax, is between 1.05 and 1.35.

Housing for an implantable medical device

An implantable medical device for stimulating a human/animal heart having a stimulation unit which stimulates the His bundle and a detection unit which detects an electrical signal at the His bundle. The device performs: a) determining a first value of a parameter of a first measuring pulse measured between a first electrode pole and a housing; b) determining a second value of the same parameter of a second measuring pulse measured between the first electrode pole and a second electrode pole; c) comparing the first and second values; d) determining, based on the comparing step, whether the first or second measuring pulses enables a higher available level control range of the analog-to-digital converter; e) measuring an impedance in a unipolar manner between the first electrode pole and the housing or in a bipolar manner between the first electrode pole and the second electrode pole depending on the determining step.

Implantable medical device for stimulating a human or animal heart employing an automatic choice between different impedance measuring modes

An implantable system for the diagnostic and/or therapeutic treatment of a human or animal patient contains a processor, a memory, a treatment unit and a remote data transmission unit. The system is characterized in that the memory includes a computer-readable program which prompts the processor to carry out the following steps when the program is being executed on the processor: a) ascertaining whether a treatment functionality of the treatment unit could jeopardize a patient in whom the system was implanted if a diagnostic and/or therapeutic treatment of the patient corresponding to the treatment functionality were to be carried out; b) deactivating the treatment functionality when a potential risk for the patient was ascertained; c) receiving reactivation data by way of the remote data transmission unit; and d) reactivating the deactivated treatment functionality based on the received reactivation data.

Implantable system for the diagnostic and/or therapeutic treatment of a human patient or an animal patient

Growing community of inventors

Berlin, Germany

Thomas Doerr